Mitchell H. Gold
Overview
Mitchell H. Gold received an average of $2M in total compensation, including $388K in salary, at Nivalis Therapeutics from 2016 to 2021.
2021Nivalis TherapeuticsExecutive Chairman and Chief Executive Officer
2020Nivalis TherapeuticsExecutive Chairman and Chief Executive Officer
2019Nivalis TherapeuticsExecutive Chairman and Chief Executive Officer
2018Nivalis TherapeuticsExecutive Chairman and Chief Executive Officer
2017Nivalis TherapeuticsExecutive Chairman and Chief Executive Officer
2016Nivalis TherapeuticsExecutive Chairman and Chief Executive Officer
Source: SEC filings on April 29, 2022, May 5, 2020, April 24, 2019, and April 24, 2018.
Related executives
We found seven more executives who work or worked at Nivalis Therapeutics.
Stanford Peng
Nivalis Therapeutics
President and Head of Research and Development
Zelanna Goldberg
Nivalis Therapeutics
Chief Medical Officer
Paul Rickey
Nivalis Therapeutics
Chief Financial Officer
Mark Litton
Nivalis Therapeutics
Chief Operating Officer
Janice Troha
Nivalis Therapeutics
Chief Operating Officer
R Carruthers
Nivalis Therapeutics
Chief Financial Officer
Jon Congleton
Nivalis Therapeutics